Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Katharina Meinecke"'
Autor:
Fabio Guidetti, Katharina Meinecke
Late Antique artefacts, and the images they carry, attest to a highly connected visual culture from ca. 300 to 800 C.E. On the one hand, the same decorative motifs and iconographies are found across various genres of visual and material culture, irre
Autor:
Craig I. Coleman PharmD, Reinhold Kreutz MD, PhD, Nitesh Sood MD, Thomas J. Bunz PharmD, PhD, Anna-Katharina Meinecke PhD, Daniel Eriksson MSc, William L. Baker PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Warfarin has been associated with renovascular calcification and worsening renal function, whereas rivaroxaban may provide a degree of renopreservation by decreasing vascular inflammation. We sought to compare rivaroxaban and warfarin’s impact on r
Externí odkaz:
https://doaj.org/article/566ac40d0ff3449d8c1f16a24a97c92a
Autor:
Ralph Klose, Ewelina Krzywinska, Magali Castells, Dagmar Gotthardt, Eva Maria Putz, Chahrazade Kantari-Mimoun, Naima Chikdene, Anna-Katharina Meinecke, Katrin Schrödter, Iris Helfrich, Joachim Fandrey, Veronika Sexl, Christian Stockmann
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Chemerin is an adipokine often downregulated in tumours. Here the authors show that chemotherapy induces chemerin production by endothelial cells, leading to cachexia, and that VEGF ablation in myeloid cells prevents cachexia in a chemerin-dependent
Externí odkaz:
https://doaj.org/article/26b59077ba8c4ef5af5427b06f0a12dc
Autor:
Thomas Wilke, Anna-Katharina Meinecke, Bernhard Schaefer, Sandra Buchwald, Daniel Eriksson, Sabrina Müller
Publikováno v:
Cardiology Research and Practice, Vol 2019 (2019)
Purpose. The patient’s perspective is becoming increasingly important in clinical and policy decisions. This study examined atrial fibrillation (AF) patient preferences for different characteristics of nonvitamin K antagonist oral anticoagulants (N
Externí odkaz:
https://doaj.org/article/1a9d6e10baf44a3ab1aa30aa891b2436
Autor:
Pierre Levy, David M. Smadja, Julie Dorey, Mondher Toumi, Anna-Katharina Meinecke, Kevin Bowrin, Jean-Baptiste Briere
Publikováno v:
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background: Little is known about the costs associated with vitamin K antagonist (VKA) treatment in patients with non-valvular atrial fibrillation (NVAF) in France. Objectives: To evaluate monthly per-patient costs attributable to VKA treatment in NV
Externí odkaz:
https://doaj.org/article/36db1862bbdc4647977d929223085b73
Autor:
Daniel, Boateng, Thomas, Kumke, Robin, Vernooij, Iris, Goetz, Anna-Katharina, Meinecke, Charlotte, Steenhuis, Diederick, Grobbee, Mira G P, Zuidgeest
Publikováno v:
Contemporary Clinical Trials. 125:107054
The GetReal Trial Tool is a decision support tool to assess the impact of design choices on generalizability of clinical trials to routine clinical practice, while taking into account the risk of bias, precision, acceptability and operational feasibi
Autor:
Katharina Meinecke
Publikováno v:
A Radical Turn? Re-appropriation, Fragmentation, and Variety in the Post-Classical World (3rd-8th c.) ISBN: 9788028001889
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c38615853f398a4887cb0e54d63f9ae2
https://doi.org/10.1484/m.convisup-eb.5.133723
https://doi.org/10.1484/m.convisup-eb.5.133723
Autor:
Katharina Meinecke
Publikováno v:
Teaching Classics in the Digital Age
Katharina Meinecke describes a form of ‘Practicing Science Communication in Digital Media: A Course to Write the “Antike in Wien” Blog and Distribute it in Social Media at the University of Vienna in 2017’. In order to make students familiar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05a4d2a9650568b757e73e74a07032a9
https://doi.org/10.38072/2703-0784/p22
https://doi.org/10.38072/2703-0784/p22
Autor:
Daniel Eriksson, Mark J. Alberts, Anna Katharina Meinecke, Thomas J. Bunz, Craig I Coleman, Brandon K. Martinez, William L. Baker
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 6:159-166
Aims There are scarce data evaluating the effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation (NVAF) patients with concomitant coronary artery disease (CAD) and/or peripheral artery disease (PAD) treated in routin
Autor:
Thomas J. Bunz, Daniel Eriksson, Reinhold Kreutz, Nitesh Sood, Anna-Katharina Meinecke, Craig I Coleman, William L. Baker
Publikováno v:
The American Journal of Medicine. 132:1078-1083
Patients with nonvalvular atrial fibrillation with stage 4 or 5 chronic kidney disease or undergoing hemodialysis were excluded from phase III randomized trials of nonvitamin K antagonist oral anticoagulants (NOACs). We sought to evaluate the effecti